A detailed history of Hemington Wealth Management transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 29 shares of BIO stock, worth $9,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 25 16.0%
Holding current value
$9,081
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$241.95 - $303.82 $967 - $1,215
4 Added 16.0%
29 $8,000
Q2 2025

Jul 24, 2025

BUY
$216.56 - $256.68 $3,464 - $4,106
16 Added 177.78%
25 $6,000
Q1 2025

May 09, 2025

SELL
$243.0 - $367.0 $486 - $734
-2 Reduced 18.18%
9 $2,000
Q4 2024

Jan 29, 2025

BUY
$313.15 - $374.28 $626 - $748
2 Added 22.22%
11 $3,000
Q3 2024

Nov 12, 2024

BUY
$263.97 - $344.64 $2,375 - $3,101
9 New
9 $3,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.